US Stock MarketDetailed Quotes

Jade Biosciences (JBIO)

Watchlist
  • 23.355
  • -0.775-3.21%
Close May 15 16:00 ET
  • 23.355
  • 0.0000.00%
Post 20:01 ET
1.15BMarket Cap-12.12P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jade Biosciences (JBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
Total revenue
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
85.79%43.45M
113.54M
70.02%34.98M
83.10%27.4M
27.78M
23.38M
20.57M
14.97M
Selling and administrative expenses
119.93%7.39M
--20.42M
120.48%6.44M
289.52%5.39M
--5.23M
--3.36M
--2.92M
--1.38M
-General and administrative expense
119.93%7.39M
--20.42M
120.48%6.44M
289.52%5.39M
--5.23M
--3.36M
--2.92M
--1.38M
Research and development costs
80.06%36.05M
--93.12M
61.68%28.54M
62.06%22.01M
--22.55M
--20.02M
--17.65M
--13.58M
Operating profit
-85.79%-43.45M
-113.54M
-70.02%-34.98M
-83.10%-27.4M
-27.78M
-23.38M
-20.57M
-14.97M
Net non-operating interest income expense
404.39%3.1M
7.78M
300.13%3.09M
480.93%2.25M
1.83M
615K
771K
388K
Non-operating interest income
404.39%3.1M
--7.78M
300.13%3.09M
480.93%2.25M
--1.83M
--615K
--771K
--388K
Other net income (expense)
99.94%-9K
-21.59M
100.18%20K
98.35%-28K
-6.18M
-15.4M
-10.9M
-1.7M
Other non- operating income (expenses)
99.94%-9K
---21.59M
100.18%20K
98.35%-28K
---6.18M
---15.4M
---10.9M
---1.7M
Income before tax
-5.72%-40.35M
-127.35M
-3.82%-31.87M
-54.67%-25.18M
-32.13M
-38.17M
-30.7M
-16.28M
Income tax
16K
58K
0
Net income
-5.76%-40.37M
-127.41M
-4.01%-31.93M
-54.67%-25.18M
-32.13M
-38.17M
-30.7M
-16.28M
Net income continuous Operations
-5.76%-40.37M
---127.41M
-4.01%-31.93M
-54.67%-25.18M
---32.13M
---38.17M
---30.7M
---16.28M
Minority interest income
Net income attributable to the parent company
-5.76%-40.37M
-127.41M
-4.01%-31.93M
-54.67%-25.18M
-32.13M
-38.17M
-30.7M
-16.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.76%-40.37M
-127.41M
-4.01%-31.93M
-54.67%-25.18M
-32.13M
-38.17M
-30.7M
-16.28M
Basic earnings per share
51.86%-0.57
-3.19
32.02%-0.6475
4.94%-0.48
-0.86
-1.1841
-0.9524
-0.5049
Diluted earnings per share
51.86%-0.57
-3.19
32.02%-0.6475
4.94%-0.48
-0.86
-1.1841
-0.9524
-0.5049
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(Q4)Dec 31, 2024(Q3)Sep 30, 2024
Total revenue 00000000
Operating revenue --0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 85.79%43.45M113.54M70.02%34.98M83.10%27.4M27.78M23.38M20.57M14.97M
Selling and administrative expenses 119.93%7.39M--20.42M120.48%6.44M289.52%5.39M--5.23M--3.36M--2.92M--1.38M
-General and administrative expense 119.93%7.39M--20.42M120.48%6.44M289.52%5.39M--5.23M--3.36M--2.92M--1.38M
Research and development costs 80.06%36.05M--93.12M61.68%28.54M62.06%22.01M--22.55M--20.02M--17.65M--13.58M
Operating profit -85.79%-43.45M-113.54M-70.02%-34.98M-83.10%-27.4M-27.78M-23.38M-20.57M-14.97M
Net non-operating interest income expense 404.39%3.1M7.78M300.13%3.09M480.93%2.25M1.83M615K771K388K
Non-operating interest income 404.39%3.1M--7.78M300.13%3.09M480.93%2.25M--1.83M--615K--771K--388K
Other net income (expense) 99.94%-9K-21.59M100.18%20K98.35%-28K-6.18M-15.4M-10.9M-1.7M
Other non- operating income (expenses) 99.94%-9K---21.59M100.18%20K98.35%-28K---6.18M---15.4M---10.9M---1.7M
Income before tax -5.72%-40.35M-127.35M-3.82%-31.87M-54.67%-25.18M-32.13M-38.17M-30.7M-16.28M
Income tax 16K58K0
Net income -5.76%-40.37M-127.41M-4.01%-31.93M-54.67%-25.18M-32.13M-38.17M-30.7M-16.28M
Net income continuous Operations -5.76%-40.37M---127.41M-4.01%-31.93M-54.67%-25.18M---32.13M---38.17M---30.7M---16.28M
Minority interest income
Net income attributable to the parent company -5.76%-40.37M-127.41M-4.01%-31.93M-54.67%-25.18M-32.13M-38.17M-30.7M-16.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.76%-40.37M-127.41M-4.01%-31.93M-54.67%-25.18M-32.13M-38.17M-30.7M-16.28M
Basic earnings per share 51.86%-0.57-3.1932.02%-0.64754.94%-0.48-0.86-1.1841-0.9524-0.5049
Diluted earnings per share 51.86%-0.57-3.1932.02%-0.64754.94%-0.48-0.86-1.1841-0.9524-0.5049
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion------------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -